Who Might Benefit From a B12 Shot
A phase 2 trial published in The Lancet gave retatrutide at doses between 4 mg and 12 mg once weekly to patients with confirmed insulin resistance
Risks, Side Effects, and What Honest Prescribing Looks Like Common and Expected Side Effects Nausea, vomiting, diarrhea, constipation most common, especially during dose titration Gastric emptying delay with gastroparesis-like symptoms clinically significant for patients on structured meal plans Fatigue, particularly early in treatment Hair thinning with higher doses or prolonged caloric restriction Dehydration secondary to gastrointestinal effects Serious but Less Common Risks Acute pancreatitis requires immediate cessation and medical management Gallbladder disease increased incidence with rapid weight loss Thyroid C-cell tumor risk observed in animal studies
Pfeiffer CM, Caudill SP, Gunter EW, Osterloh J, Sampson EJ
Recommended for people who can manage or are comfortable with injections
A former critical care nurse, she leads nearly 25,000 team members and physicians overseeing the health and well-being of communities throughout the state
